Skip to content

Is Computer-Guided Bone Removal from the Hip Safe and Effective for Lower Back Fusion Surgery? A Patient Study

Outcome of Percutaneous Navigation-Guided Posterior Iliac Crest Bone Graft Harvesting in Primary and Revision Minimally Invasive Lumbar Interbody Fusion - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099017
Enrollment
60
Registered
2025-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M51- Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders

Interventions

Sponsors

Stavya Spine Hospital and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. History of prior lumbar instrumentation or decompression at the index level requiring fusion. 2. Adjacent segment degeneration 3. Planned MIS Lumbar fusion Single-level or Multi level fusion for degenerative disc disease, spondylolisthesis and degenerative scoliosis. 4. Willing and able to provide consent and comply with postoperative follow-up

Exclusion criteria

Exclusion criteria: 1. Presence of lumbar spine trauma, infection, neoplasm, or major spinal deformity other than degenerative scolios. 2. Patient refusal to participate or inability/unwillingness to complete scheduled followup evaluations.

Design outcomes

Primary

MeasureTime frame
1 .Operative time bone graft harvesting time: targeting to closure 2. Estimated blood loss 3. Transfusion if any 4. Measurement of the graft volume 5. Side of graft harvesting 6. Intraoperative complications 7. Length of postoperative stay 8. Ambulation status 9. Analgesics usage 10. Post op complications 11. To assess the violation of SI joints. 12. To assess the trajectory of the graft harvested iliac crest 13. To assess the breach in the inner or outer table of iliac crest 14. To assess the depth of graft harvested 15. Size- Length and width of the surgical scar 16. Presence of hypertrophic scar 17. Pain VAS Score donor site. Timepoint: Patients will be followed up at regular intervals of 2 weeks ,6 weeks ,3 months, 6 months(Baseline- Day 0) .

Secondary

MeasureTime frame
NIL.Timepoint: NIL.

Countries

India

Contacts

Public ContactDr Ajay Krishnan

Stavya Spine Hospital And Research Institute

drajaykrishnan@yahoo.co.in09824302768

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026